Good news | Tianjiquan G SLT semiconductor laser therapy device has been listed in the "China Drug Administration Yearbook" (2023)
2024-06-19
Recently, the 2023 edition of the "China Drug Administration Yearbook" published by the State Administration for Market Regulation has been officially released. Tianjiquan Group has been listed in the "China Drug Administration Yearbook" (2023) for its excellent corporate image, high-quality medical products, and outstanding services. This not only demonstrates the outstanding achievements of Tianjiquan Group in developing innovative products and the market position of the brand, but also once again proves the recognition of Tianjiquan and its research and development products by the National Medical Products Administration.
China Drug Administration Yearbook (2023)
The book "China Drug Administration Yearbook" (2023) focuses on the Tianjiquan G SLT semiconductor laser therapy device. Semiconductor laser therapy device is non-invasive and infection free; Small size and light weight, easy to operate, not limited by time or location; Laser irradiation of the nasal cavity or acupoints is used as an adjuvant therapy for vascular headaches, cerebral infarction, and chronic cardiovascular and cerebrovascular diseases after traumatic brain injury.
China Drug Administration Yearbook (2023) China Drug Administration Yearbook (2023) Tianjiquan Page Details Tianjiquan Group was established in 2001 and is a national high-tech enterprise. It has been deeply involved in the health industry for more than 20 years and always adheres to the concept of "innovation first, customer first, quality first, and service first". Under the leadership of Chairman and CEO Shi Yanbao, we focus on cutting-edge technology research, attach great importance to technological innovation and product development, and have completed the research and development of multiple new products and patents. For over 20 years, Tianjiquan Group has continuously integrated its advantageous resources and cultivated and introduced a group of outstanding researchers, adhering to technological innovation. With products such as QRS quantum resonance health information detector and G SLT semiconductor laser therapy device, Tianjiquan Group has become a leader in the field of green health and a preferred brand for consumer healthcare and medical care.
The board of directors of Tianjiquan Group attaches great importance to product innovation and research and development
Since its establishment more than 20 years ago, Tianjiquan Group has always adhered to the original intention of "boundless love, spreading health; unique goal, treating diseases and saving lives", down-to-earth, adapting to the market and innovating, accumulating rich experience and strong strength. In the future, Tianjiquan Group will live up to expectations, forge ahead, continuously strengthen technological breakthroughs, strive to improve the level of scientific and technological research and development, develop more and better health products to serve the public, and contribute to the development and takeoff towards national brands!
